Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The group focuses on treatment, research, policy and education around HIV and hepatitis C.
Diagnosed with hepatitis C and HIV, Gloria Searson became a powerful advocate for many.
People who have a low CD4 count, have cirrhosis and take certain hep C drug regimens are less likely to be cured.
Cured of hepatitis C the hard way, Glenna McCarthy’s mission is to help others take advantage of the new easier-to-take treatments.
Human rights activist Philip Baldwin writes about his experiences living with hepatitis C and HIV, and his treatment for hep C.
Hepatitis C takes this storyteller from fear to action, helping others along the way.
The update includes a new combination therapy that can treat all six genotypes of HCV, a new HIV medication and PrEP.
This advocate’s call to action began with an injury, then a viral hepatitis diagnosis, then HIV.
Even those who did not qualify for a treatment shorter than 12 weeks did well on the regimen in a real-world study.
Gilead Sciences’ HCV combo tablet regimen of Sovaldi and velpatasvir can be combined safely with most “boosted” antiretroviral treatment...
Real-world results of eight weeks of the hepatitis C virus treatment Harvoni (ledipasvir/sofosbuvir) are excellent.
Curing hepatitis C virus (HCV) is associated with a reduced risk of death, kidney disease and diabetes.
People with hepatitis C very rarely have a viral relapse after acheiving a sustained virologic response 12 weeks after finishing treatment.
A intensive care coordination program showed a high level of success in getting a group of urban people with hep C cured of the virus.
Six weeks of Harvoni cured all acute hep C infections in HIV-positive people with HCV viral loads below 7 million in a recent small trial.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.